Clinical Trial Update: WF and PR OCTA in Diabetic Retinopathy

View source ↗

Summary

A clinical trial update on the WF and PR OCTA approach in diabetic retinopathy; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Snippet

Sponsor: Oregon Health and Science University | Conditions: Diabetic Retinopathy | Status: ACTIVE_NOT_RECRUITING